DEALTALK-Bayer could set sights on big acquisition even as deal options dwindle

FRANKFURT, Dec 18 (Reuters) - Bayer is likely to seek a major life sciences M&A deal in the next few years, according to banking sources, as its absence from a recent wave of consolidation could undermine its position in markets such as crop protection and animal health.